Associations between the proportion of fat-free mass loss during weight loss, changes in appetite, and subsequent weight change: results from a randomized 2-stage dietary intervention trial
Jake Turicchi(University of Leeds), R. James Stubbs(University of Leeds), Cristiana Duarte(York St John University), Arne Astrup(Novo Nordisk Foundation), Mark Hopkins(University of Leeds), Thomas Meinert Larsen(University of Copenhagen), Joanna Michałowska, Graham Finlayson(Musgrave Park Hospital), Ruairi O’Driscoll(University of Leeds), Marleen A. van Baak(Maastricht University)
Cited by 59
Related Papers
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
|New England Journal of Medicine|2015|2.6k
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
|The Lancet|2007|1.1k
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|857
Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC)
|Nutrition Metabolism and Cardiovascular Diseases|2015|691
The development of compassionate engagement and action scales for self and others
|Journal of Compassionate Health Care|2017|528